Tenet Healthcare Corporation (NYSE: THC) Stock Competitors & Peer Comparison
See THC's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for THC and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| THC | $257.00 | -0.36% | 20.8B | 14.95 | $17.24 | N/A |
| HCA | $427.84 | -1.10% | 93.4B | 14.90 | $28.96 | +0.71% |
| EHC | $122.01 | -1.62% | 12.3B | 21.15 | $5.84 | +0.62% |
| FMS | $22.45 | -2.16% | 12B | 8.37 | $2.66 | +3.89% |
| DVA | $176.85 | -0.69% | 11.2B | 13.68 | $12.80 | N/A |
| UHS | $174.33 | -1.77% | 10.6B | 7.80 | $22.54 | +0.45% |
| ENSG | $172.04 | -2.45% | 10.2B | 25.44 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $506.05 | -1.60% | 6.7B | 23.70 | $21.61 | +0.49% |
| PACS | $41.58 | -3.44% | 6.7B | 22.36 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
THC vs HCA Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, HCA has a market cap of 93.4B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while HCA trades at $427.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas HCA's P/E ratio is 14.90. In terms of profitability, THC's ROE is +0.51%, compared to HCA's ROE of -1.13%. Regarding short-term risk, THC is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for THC.Check HCA's competition here
Encompass Health Corporation (NYSE: EHC)
THC vs EHC Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, EHC has a market cap of 12.3B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while EHC trades at $122.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas EHC's P/E ratio is 21.15. In terms of profitability, THC's ROE is +0.51%, compared to EHC's ROE of +0.25%. Regarding short-term risk, THC is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for THC.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
THC vs FMS Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, FMS has a market cap of 12B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while FMS trades at $22.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas FMS's P/E ratio is 8.37. In terms of profitability, THC's ROE is +0.51%, compared to FMS's ROE of +0.07%. Regarding short-term risk, THC is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for THC.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
THC vs DVA Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, DVA has a market cap of 11.2B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while DVA trades at $176.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas DVA's P/E ratio is 13.68. In terms of profitability, THC's ROE is +0.51%, compared to DVA's ROE of -1.24%. Regarding short-term risk, THC is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for THC.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
THC vs UHS Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, UHS has a market cap of 10.6B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while UHS trades at $174.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas UHS's P/E ratio is 7.80. In terms of profitability, THC's ROE is +0.51%, compared to UHS's ROE of +0.21%. Regarding short-term risk, THC is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for THC.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
THC vs ENSG Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, ENSG has a market cap of 10.2B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while ENSG trades at $172.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas ENSG's P/E ratio is 25.44. In terms of profitability, THC's ROE is +0.51%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, THC is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for THC.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
THC vs OSH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas OSH's P/E ratio is -17.65. In terms of profitability, THC's ROE is +0.51%, compared to OSH's ROE of +4.64%. Regarding short-term risk, THC is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for THC.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
THC vs CHE Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, CHE has a market cap of 6.7B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while CHE trades at $506.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas CHE's P/E ratio is 23.70. In terms of profitability, THC's ROE is +0.51%, compared to CHE's ROE of +0.29%. Regarding short-term risk, THC is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for THC.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
THC vs PACS Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while PACS trades at $41.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas PACS's P/E ratio is 22.36. In terms of profitability, THC's ROE is +0.51%, compared to PACS's ROE of +0.27%. Regarding short-term risk, THC is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for THC.Check PACS's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
THC vs HIMS Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, HIMS has a market cap of 6.4B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while HIMS trades at $30.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas HIMS's P/E ratio is -44.84. In terms of profitability, THC's ROE is +0.51%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, THC is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for THC.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
THC vs LHCG Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas LHCG's P/E ratio is 82.83. In terms of profitability, THC's ROE is +0.51%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, THC is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for THC.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
THC vs LFST Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, LFST has a market cap of 4.6B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while LFST trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas LFST's P/E ratio is 89.55. In terms of profitability, THC's ROE is +0.51%, compared to LFST's ROE of +0.03%. Regarding short-term risk, THC is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for THC.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
THC vs CON Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, CON has a market cap of 4.5B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while CON trades at $34.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas CON's P/E ratio is 22.23. In terms of profitability, THC's ROE is +0.51%, compared to CON's ROE of +0.47%. Regarding short-term risk, THC is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for THC.Check CON's competition here
National HealthCare Corporation (AMEX: NHC)
THC vs NHC Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while NHC trades at $221.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas NHC's P/E ratio is 28.53. In terms of profitability, THC's ROE is +0.51%, compared to NHC's ROE of +0.13%. Regarding short-term risk, THC is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for THC.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
THC vs OPCH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, OPCH has a market cap of 3.4B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while OPCH trades at $22.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas OPCH's P/E ratio is 13.26. In terms of profitability, THC's ROE is +0.51%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, THC is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for THC.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
THC vs AMED Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AMED's P/E ratio is 39.30. In terms of profitability, THC's ROE is +0.51%, compared to AMED's ROE of +0.11%. Regarding short-term risk, THC is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for THC.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
THC vs AVAH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AVAH has a market cap of 2.8B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AVAH trades at $12.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AVAH's P/E ratio is 18.79. In terms of profitability, THC's ROE is +0.51%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, THC is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for THC.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
THC vs BKD Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, BKD has a market cap of 2.6B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while BKD trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas BKD's P/E ratio is -18.93. In terms of profitability, THC's ROE is +0.51%, compared to BKD's ROE of +4.06%. Regarding short-term risk, THC is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for THC.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
THC vs ACHC Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while ACHC trades at $27.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas ACHC's P/E ratio is 14.09. In terms of profitability, THC's ROE is +0.51%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, THC is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for THC.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
THC vs GRDN Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while GRDN trades at $40.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas GRDN's P/E ratio is 35.69. In terms of profitability, THC's ROE is +0.51%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, THC is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for THC.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
THC vs MD Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, MD has a market cap of 2.1B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while MD trades at $25.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas MD's P/E ratio is 11.62. In terms of profitability, THC's ROE is +0.51%, compared to MD's ROE of +0.20%. Regarding short-term risk, THC is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for THC.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
THC vs ADUS Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while ADUS trades at $111.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas ADUS's P/E ratio is 16.91. In terms of profitability, THC's ROE is +0.51%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, THC is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for THC.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
THC vs SEM Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas SEM's P/E ratio is 15.43. In terms of profitability, THC's ROE is +0.51%, compared to SEM's ROE of +0.08%. Regarding short-term risk, THC is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for THC.Check SEM's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
THC vs SGRY Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while SGRY trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas SGRY's P/E ratio is 36.95. In terms of profitability, THC's ROE is +0.51%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, THC is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for THC.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
THC vs AMEH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AMEH's P/E ratio is 39.25. In terms of profitability, THC's ROE is +0.51%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, THC is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for THC.Check AMEH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
THC vs SNDA Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while SNDA trades at $37.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas SNDA's P/E ratio is -6.07. In terms of profitability, THC's ROE is +0.51%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, THC is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for THC.Check SNDA's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
THC vs ASTH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while ASTH trades at $35.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas ASTH's P/E ratio is 42.71. In terms of profitability, THC's ROE is +0.51%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, THC is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for THC.Check ASTH's competition here
Ardent Health Inc. (NYSE: ARDT)
THC vs ARDT Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while ARDT trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas ARDT's P/E ratio is 8.54. In terms of profitability, THC's ROE is +0.51%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, THC is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for THC.Check ARDT's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
THC vs NUTX Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, NUTX has a market cap of 1.4B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while NUTX trades at $212.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas NUTX's P/E ratio is 8.31. In terms of profitability, THC's ROE is +0.51%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, THC is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for THC.Check NUTX's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
THC vs HCSG Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, HCSG has a market cap of 1.4B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while HCSG trades at $20.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas HCSG's P/E ratio is 16.72. In terms of profitability, THC's ROE is +0.51%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, THC is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for THC.Check HCSG's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
THC vs PNTG Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while PNTG trades at $39.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas PNTG's P/E ratio is 30.68. In terms of profitability, THC's ROE is +0.51%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, THC is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for THC.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
THC vs AMN Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AMN has a market cap of 1.4B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AMN trades at $35.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AMN's P/E ratio is 11.61. In terms of profitability, THC's ROE is +0.51%, compared to AMN's ROE of +0.15%. Regarding short-term risk, THC is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for THC.Check AMN's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
THC vs USPH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, USPH has a market cap of 1.3B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while USPH trades at $86.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas USPH's P/E ratio is 33.93. In terms of profitability, THC's ROE is +0.51%, compared to USPH's ROE of -0.01%. Regarding short-term risk, THC is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for THC.Check USPH's competition here
Agilon Health, Inc. (NYSE: AGL)
THC vs AGL Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AGL has a market cap of 1.3B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AGL trades at $79.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AGL's P/E ratio is -5.08. In terms of profitability, THC's ROE is +0.51%, compared to AGL's ROE of -1.19%. Regarding short-term risk, THC is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for THC.Check AGL's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
THC vs BKDT Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas BKDT's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, THC is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for THC.Check BKDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
THC vs INNV Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while INNV trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas INNV's P/E ratio is -449.00. In terms of profitability, THC's ROE is +0.51%, compared to INNV's ROE of -0.01%. Regarding short-term risk, THC is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for THC.Check INNV's competition here
Talkspace, Inc. (NASDAQ: TALK)
THC vs TALK Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas TALK's P/E ratio is 774.34. In terms of profitability, THC's ROE is +0.51%, compared to TALK's ROE of +0.00%. Regarding short-term risk, THC is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for THC.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
THC vs EHAB Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas EHAB's P/E ratio is -197.14. In terms of profitability, THC's ROE is +0.51%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, THC is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for THC.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
THC vs STLN Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, STLN has a market cap of 650.9M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while STLN trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas STLN's P/E ratio is -21.33. In terms of profitability, THC's ROE is +0.51%, compared to STLN's ROE of +2.10%. Regarding short-term risk, THC is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for THC.Check STLN's competition here
GMR Solutions Inc. (NYSE: GMRS)
THC vs GMRS Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, GMRS has a market cap of 531.2M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while GMRS trades at $9.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas GMRS's P/E ratio is -4.84. In terms of profitability, THC's ROE is +0.51%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, THC is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for THC.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
THC vs TOI Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas TOI's P/E ratio is -14.25. In terms of profitability, THC's ROE is +0.51%, compared to TOI's ROE of +2.10%. Regarding short-term risk, THC is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for THC.Check TOI's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
THC vs MCTA Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas MCTA's P/E ratio is 419.36. In terms of profitability, THC's ROE is +0.51%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, THC is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for THC.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
THC vs SRTA Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, SRTA has a market cap of 441.3M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while SRTA trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas SRTA's P/E ratio is -24.04. In terms of profitability, THC's ROE is +0.51%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, THC is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for THC.Check SRTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
THC vs CYH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, CYH has a market cap of 411.7M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while CYH trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas CYH's P/E ratio is 4.00. In terms of profitability, THC's ROE is +0.51%, compared to CYH's ROE of +0.21%. Regarding short-term risk, THC is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for THC.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
THC vs AUNA Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AUNA has a market cap of 374.9M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AUNA trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AUNA's P/E ratio is 4.56. In terms of profitability, THC's ROE is +0.51%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, THC is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for THC.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
THC vs VMD Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, VMD has a market cap of 351.6M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while VMD trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas VMD's P/E ratio is 25.64. In terms of profitability, THC's ROE is +0.51%, compared to VMD's ROE of +0.10%. Regarding short-term risk, THC is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for THC.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
THC vs CSU Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas CSU's P/E ratio is 0.67. In terms of profitability, THC's ROE is +0.51%, compared to CSU's ROE of -0.33%. Regarding short-term risk, THC is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for THC.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
THC vs AIRS Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AIRS has a market cap of 127M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AIRS trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AIRS's P/E ratio is -60.00. In terms of profitability, THC's ROE is +0.51%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, THC is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for THC.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
THC vs JYNT Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, JYNT has a market cap of 110.5M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while JYNT trades at $7.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas JYNT's P/E ratio is 77.50. In terms of profitability, THC's ROE is +0.51%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, THC is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for THC.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
THC vs FVE Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas FVE's P/E ratio is -5.64. In terms of profitability, THC's ROE is +0.51%, compared to FVE's ROE of -0.15%. Regarding short-term risk, THC is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for THC.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
THC vs KDLYW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas KDLYW's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, THC is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for THC.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
THC vs PARK Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, PARK has a market cap of 92.6M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while PARK trades at $20.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas PARK's P/E ratio is 27.70. In terms of profitability, THC's ROE is +0.51%, compared to PARK's ROE of -0.18%. Regarding short-term risk, THC is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for THC.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
THC vs BTMD Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, BTMD has a market cap of 54.7M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while BTMD trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas BTMD's P/E ratio is 11.27. In terms of profitability, THC's ROE is +0.51%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, THC is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for THC.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
THC vs ALR Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas ALR's P/E ratio is -1.11. In terms of profitability, THC's ROE is +0.51%, compared to ALR's ROE of -0.15%. Regarding short-term risk, THC is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for THC.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
THC vs DCGO Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, DCGO has a market cap of 36.4M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while DCGO trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas DCGO's P/E ratio is -0.20. In terms of profitability, THC's ROE is +0.51%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, THC is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for THC.Check DCGO's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
THC vs IMAC Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas IMAC's P/E ratio is -2.27. In terms of profitability, THC's ROE is +0.51%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, THC is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for THC.Check IMAC's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
THC vs CCEL Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, CCEL has a market cap of 33.1M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while CCEL trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas CCEL's P/E ratio is -13.67. In terms of profitability, THC's ROE is +0.51%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, THC is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for THC.Check CCEL's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
THC vs EUDA Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, EUDA has a market cap of 29.2M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while EUDA trades at $15.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas EUDA's P/E ratio is -10.53. In terms of profitability, THC's ROE is +0.51%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, THC is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for THC.Check EUDA's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
THC vs PIIIW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, PIIIW has a market cap of 29.2M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas PIIIW's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, THC is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for THC.Check PIIIW's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
THC vs PIII Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, PIII has a market cap of 21.4M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while PIII trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas PIII's P/E ratio is -0.20. In terms of profitability, THC's ROE is +0.51%, compared to PIII's ROE of +1.61%. Regarding short-term risk, THC is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for THC.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO-WT)
THC vs CANO-WT Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, THC is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for THC.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
THC vs AIH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AIH's P/E ratio is -2.78. In terms of profitability, THC's ROE is +0.51%, compared to AIH's ROE of +1.16%. Regarding short-term risk, THC is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for THC.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
THC vs CANO Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas CANO's P/E ratio is -0.01. In terms of profitability, THC's ROE is +0.51%, compared to CANO's ROE of -1.49%. Regarding short-term risk, THC is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for THC.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
THC vs FPCG Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas FPCG's P/E ratio is 0.09. In terms of profitability, THC's ROE is +0.51%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, THC is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for THC.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
THC vs FTRP Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas FTRP's P/E ratio is -1.22. In terms of profitability, THC's ROE is +0.51%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, THC is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for THC.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
THC vs AMS Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AMS trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AMS's P/E ratio is -5.66. In terms of profitability, THC's ROE is +0.51%, compared to AMS's ROE of -0.07%. Regarding short-term risk, THC is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for THC.Check AMS's competition here
ModivCare Inc. (NASDAQ: MODV)
THC vs MODV Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas MODV's P/E ratio is -0.06. In terms of profitability, THC's ROE is +0.51%, compared to MODV's ROE of +1.36%. Regarding short-term risk, THC is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for THC.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
THC vs GBNH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas GBNH's P/E ratio is -0.06. In terms of profitability, THC's ROE is +0.51%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, THC is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for THC.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
THC vs RHE Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas RHE's P/E ratio is -1.79. In terms of profitability, THC's ROE is +0.51%, compared to RHE's ROE of -1.31%. Regarding short-term risk, THC is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for THC.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
THC vs RHE-PA Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, THC's ROE is +0.51%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, THC is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for THC.Check RHE-PA's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
THC vs AIDX Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AIDX has a market cap of 5.1M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AIDX trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AIDX's P/E ratio is -0.78. In terms of profitability, THC's ROE is +0.51%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, THC is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for THC.Check AIDX's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
THC vs BMGL Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, BMGL has a market cap of 4.9M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while BMGL trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas BMGL's P/E ratio is -0.59. In terms of profitability, THC's ROE is +0.51%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, THC is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for THC.Check BMGL's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
THC vs STLNW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, STLNW has a market cap of 4.8M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while STLNW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas STLNW's P/E ratio is -0.16. In terms of profitability, THC's ROE is +0.51%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, THC is more volatile compared to STLNW. This indicates higher risk in terms of short-term price fluctuations for THC.Check STLNW's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
THC vs TOIIW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, THC's ROE is +0.51%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, THC is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for THC.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
THC vs IMACW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas IMACW's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, THC is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for THC.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
THC vs EDVA Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, EDVA has a market cap of 1.1M. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while EDVA trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas EDVA's P/E ratio is -0.01. In terms of profitability, THC's ROE is +0.51%, compared to EDVA's ROE of N/A. Regarding short-term risk, THC is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for THC.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
THC vs EUDAW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, EUDAW has a market cap of 998.1K. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas EUDAW's P/E ratio is -0.02. In terms of profitability, THC's ROE is +0.51%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, THC is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for THC.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
THC vs CCM Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, CCM has a market cap of 482.7K. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while CCM trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas CCM's P/E ratio is -1.11. In terms of profitability, THC's ROE is +0.51%, compared to CCM's ROE of +0.06%. Regarding short-term risk, THC is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for THC.Check CCM's competition here
Talkspace, Inc. (NASDAQ: TALKW)
THC vs TALKW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas TALKW's P/E ratio is 0.00. In terms of profitability, THC's ROE is +0.51%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, THC is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for THC.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
THC vs MNDR Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, MNDR has a market cap of 30.8K. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while MNDR trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas MNDR's P/E ratio is -0.03. In terms of profitability, THC's ROE is +0.51%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, THC is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for THC.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
THC vs NIVFW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, NIVFW has a market cap of 20.9K. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while NIVFW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas NIVFW's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, THC is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for THC.Check NIVFW's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
THC vs TNONW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, TNONW has a market cap of 5.4K. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while TNONW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas TNONW's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to TNONW's ROE of N/A. Regarding short-term risk, THC is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for THC.Check TNONW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
THC vs NIVF Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, NIVF has a market cap of 4.5K. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while NIVF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas NIVF's P/E ratio is 0.04. In terms of profitability, THC's ROE is +0.51%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, THC is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for THC.Check NIVF's competition here
Kindred Healthcare, Inc. (NYSE: KND)
THC vs KND Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, KND has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas KND's P/E ratio is -1.14. In terms of profitability, THC's ROE is +0.51%, compared to KND's ROE of -0.53%. Regarding short-term risk, THC is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for THC.Check KND's competition here
New Frontier Health Corporation (NYSE: NFH)
THC vs NFH Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, NFH has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas NFH's P/E ratio is -19.75. In terms of profitability, THC's ROE is +0.51%, compared to NFH's ROE of -0.06%. Regarding short-term risk, THC is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for THC.Check NFH's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
THC vs TVTY Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas TVTY's P/E ratio is 19.06. In terms of profitability, THC's ROE is +0.51%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, THC is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for THC.Check TVTY's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
THC vs SLHGP Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, THC's ROE is +0.51%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, THC is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for THC.Check SLHGP's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
THC vs TLMDW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas TLMDW's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, THC is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for THC.Check TLMDW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
THC vs DVCR Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas DVCR's P/E ratio is 28.34. In terms of profitability, THC's ROE is +0.51%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, THC is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for THC.Check DVCR's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
THC vs SLHG Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas SLHG's P/E ratio is -1.48. In terms of profitability, THC's ROE is +0.51%, compared to SLHG's ROE of N/A. Regarding short-term risk, THC is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for THC.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
THC vs AFAM Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas AFAM's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, THC is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for THC.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
THC vs TLMD Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas TLMD's P/E ratio is -1.60. In terms of profitability, THC's ROE is +0.51%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, THC is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for THC.Check TLMD's competition here
Hanger, Inc. (NYSE: HNGR)
THC vs HNGR Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas HNGR's P/E ratio is 19.71. In terms of profitability, THC's ROE is +0.51%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, THC is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for THC.Check HNGR's competition here
DocGo Inc. (NASDAQ: DCGOW)
THC vs DCGOW Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas DCGOW's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, THC is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for THC.Check DCGOW's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
THC vs ATIP-WT Comparison September 2026
Tenet Healthcare Corporation (NYSE: THC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THC stands at 20.8B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, THC is priced at $257.00 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THC currently has a P/E ratio of 14.95, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, THC's ROE is +0.51%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, THC is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for THC.Check ATIP-WT's competition here